• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 3. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 4. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 5. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952

Ethyl 5-pyrimidinecarboxylate (CAS No. 40929-50-8): A Key Intermediate in Modern Pharmaceutical Research

Ethyl 5-pyrimidinecarboxylate, identified by its Chemical Abstracts Service (CAS) number 40929-50-8, is a significant compound in the realm of pharmaceutical chemistry. This organic ester, derived from pyrimidine, has garnered considerable attention due to its versatile applications in drug development and synthetic chemistry. The compound's structure, featuring a pyrimidine core linked to an ethyl carboxylate group, makes it a valuable intermediate for constructing more complex molecules.

The utility of Ethyl 5-pyrimidinecarboxylate stems from its reactivity and the broad spectrum of biological activities associated with pyrimidine derivatives. Pyrimidines are fundamental heterocyclic aromatic compounds that play crucial roles in nucleic acids and various metabolic pathways. Consequently, derivatives of pyrimidine have been extensively explored for their pharmacological potential.

In recent years, the demand for novel therapeutic agents has driven research into innovative synthetic routes and functionalized pyrimidine derivatives. Ethyl 5-pyrimidinecarboxylate serves as a cornerstone in this endeavor, facilitating the synthesis of biologically active compounds targeting diverse diseases. Its role in constructing pharmacophores has been particularly highlighted in the development of antiviral, anticancer, and anti-inflammatory agents.

One of the most compelling aspects of Ethyl 5-pyrimidinecarboxylate is its adaptability in chemical modifications. The ethyl carboxylate group can be readily transformed into other functional moieties, such as amides, esters, or carboxylic acids, enabling the creation of structurally diverse analogs. This flexibility is crucial for optimizing drug candidates through structure-activity relationship (SAR) studies.

The synthesis of Ethyl 5-pyrimidinecarboxylate typically involves multi-step organic reactions, often starting from commercially available precursors like malonic acid or diethyl oxalate. Advanced synthetic methodologies, including catalytic hydrogenation and palladium-catalyzed cross-coupling reactions, have been employed to enhance yield and purity. These advancements reflect the ongoing evolution of synthetic organic chemistry and its impact on pharmaceutical manufacturing.

Recent studies have demonstrated the compound's significance in medicinal chemistry. For instance, researchers have utilized Ethyl 5-pyrimidinecarboxylate to develop novel inhibitors targeting enzymes involved in viral replication. The pyrimidine scaffold mimics natural nucleobases, allowing for precise interactions with biological targets. Such findings underscore the compound's potential as a building block for next-generation therapeutics.

The role of Ethyl 5-pyrimidinecarboxylate extends beyond academic research; it has found applications in industrial settings where high-throughput screening and combinatorial chemistry are employed. The compound's well-documented properties make it an attractive candidate for library synthesis programs aimed at discovering new drug candidates.

From a regulatory perspective, Ethyl 5-pyrimidinecarboxylate benefits from established safety profiles and handling protocols, ensuring its integration into pharmaceutical workflows is seamless. Its stability under various storage conditions further enhances its practicality as an intermediate in large-scale production.

The future prospects of Ethyl 5-pyrimidinecarboxylate are promising, with ongoing research exploring its applications in areas such as gene therapy and personalized medicine. The ability to modify its structure opens doors to tailored therapeutic solutions that address specific patient needs.

In conclusion, Ethyl 5-pyrimidinecarboxylate (CAS No. 40929-50-8) is a pivotal compound in modern pharmaceutical research. Its versatility as a synthetic intermediate and its potential to contribute to the development of novel drugs position it as a cornerstone of medicinal chemistry innovation. As research continues to uncover new applications and synthetic strategies, the importance of this compound is set to grow further.

• 5571-03-9(5-Pyrimidinecarboxylic acid, 2-methyl-, methyl ester (7CI,8CI,9CI))
• 352535-06-9(5-Pyrimidinecarboxylicacid, sodium salt (1:1))
• 308348-93-8(Methyl 2-aminopyrimidine-5-carboxylate)
• 4595-61-3(pyrimidine-5-carboxylic acid)
• 2134-38-5(Ethyl 2-methylpyrimidine-5-carboxylate)
• 34253-01-5(Methyl pyrimidine-5-carboxylate)
• 57401-76-0(Ethyl 2-aminopyrimidine-5-carboxylate)
• 287714-35-6(Methyl 2-chloropyrimidine-5-carboxylate)
• 89793-12-4(Ethyl 2-chloropyrimidine-5-carboxylate)
• 409357-05-7(5-Pyrimidinecarboxylicacid, hydrochloride (1:1))